Wednesday, 17 July 2019

Pharma News

  • BP and Diabetes drugs available at $0.04 per day

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 14 Aug, 2012

    Bangalore: Considering the rising prices of products and services in India, Ozone Pharmaceuticals, one of the leading prescription drug manufacturing and marketing company from India, intro...Read more

  • GSK files for approval on melanoma drug combo

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2013

    Singapore: Britian's leading drug maker, GlaxoSmithKline has filed for US Food and Drug Administration (US FDA) approval for its melanoma drug combo earlier than other competitors. Using d...Read more

  • Novartis spends $160 mn to jumpstart factory

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 29 Apr, 2013

    Singapore: Novartis is going to invest $160 million (CHF150 million) until 2020 to bolster its production site near Geneva. The firm was contemplating a shut down of the site 18 months ago....Read more

  • IDT appoints Paul MacLeman as CEO

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 08 Apr, 2013

    Singapore: IDT Australia appointed Dr Paul MacLeman as CEO, effective April 15, 2013. Dr MacLeman was recently the CEO of Melbourne-based biotechnology company Genetic Technologies, where h...Read more

  • Hydrogel-based delivery

    Pharma |  News | By Nandita Singh | 0 Comment | 14 Mar, 2012

    The Institute of Bioengineering and Nanotechnology, Singapore, has developed an injectable biodegradable hydrogel system using enzyme-mediated reaction for drug delivery and tissue engineer...Read more

  • Edison Pharma, DSP enter $4 bn metablosim drug deal

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 04 Feb, 2014

    Singapore: US-based Edison Pharmaceuticals has entered into a strategic alliance valued up to $4.295 billion with Japan's Dainippon Sumitomo Pharma (DSP) for the development of drugs target...Read more

  • India, China to witness high growth of multiple sclerosis in 10 yrs: GlobalData

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 20 May, 2014

    Singapore: Market analysis firm, GlobalData, reports that among counries including US, Canada, France, Germany, Italy, Spain, UK, Japan, China and India, India will have the highest increas...Read more

  • Dr Brian McNamee to step down from CSL

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2012

    Singapore: After 23 years of being at the helm of CSL, Dr Brian McNamee will leave the firm in July 2013 and will be succeeded by Mr Paul Perreault, who is currently the president of CSL Be...Read more

  • TWi Pharma gets FDA nod for ADHD drug

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 15 May, 2013

    Singapore: Taiwan-based TWi Pharmaceuticals has received tentative approval for its Abbreviated New Drug Application (ANDA) for Guanfacine Hydrochloride extended release tablets 1mg, 2mg, 3...Read more

  • India's Science & Technology minister passes away

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 14 Aug, 2012

    Bangalore: Mr Vilasrao Deshmukh, the Science and Technology minister, Government of India, passed away at a hospital in Chennai this afternoon after a brief illness at the age of 67. He was...Read more

  • Takeda, M2Gen set to boost Health Informatics-based cancer treatment

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 20 Jun, 2016

    Japanese pharma giant Takeda Pharmaceutical Company Limited and M2Gen, a healthcare informatics solutions company, have established a new collaboration to generate broad genomic data from c...Read more

  • AnGes, Mitsubishi Tanabe sign MoU to market Collategene

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

    Singapore: AnGes MG entered into a definitive agreement with Mitsubishi Tanabe Pharma for the exclusive marketing rights of Collategene (DNA plasmid with HGF gene) as a treatment for peri...Read more

  • Wockhardt to market generic of GSK Parkinson's drug

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 29 Aug, 2012

    Mumbai: Pharmaceutical and biotechnology major Wockhardt received US FDA approval for marketing 2mg, 4mg, 6mg, 8mg and 12mg extended-release tablets with generic version of GlaxoSmithKline'...Read more

  • 5 major policy developments of 2012

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 20 Dec, 2012

    The Year 2012 has seen crucial policy changes in the bioscience industry around the world. These changes that have taken place in 2012 hope to have an impact on the businesses of pharma, bi...Read more

  • Udit Batra to head Merck-Sigma Aldrich merger firm

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 16 Apr, 2015

    Singapore: Mr Udit Batra, CEO and president of German firm, Merck's lifescience business, will be heading the business of Merck post acquisition of Sigma-Aldrich. The planned $17 billion t...Read more

  • 50 Indian companies to invest $500mn in the US

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Hyderabad: 50 Indian companies have recently indicated they will collectively invest over $500 million in the US market by either acquiring a US business or setting up their own operations...Read more

  • Sandoz launches trial with Amgen biosimilar

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: The generics unit of Novartis, Sandoz, has launched a late-stage trial with its biosimilar version of Amgen's Enbrel. With this, Novartis has consolidated its leading position in...Read more

  • Lupin gets approval for oral contraceptive

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Bangalore: Pharma major, Lupin, announced that its subsidiary Lupin Pharmaceuticals Inc. (collectively Lupin) has received final approval for its oral contraceptive Kurvelo® Tablets (Levo...Read more



Podcast

 

Survey Box

Is Blockchain offering a solution to the healthcare industry?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls